Downregulation of RIPK4 Expression Inhibits Epithelial-Mesenchymal Transition in Ovarian Cancer through IL-6
Yi Huan(Fujian Medical University), Rong Zhang(Xian Central Hospital)
Cited by 13
Related Papers
A randomized Phase III trial of neoadjuvant recombinant human endostatin, docetaxel and epirubicin as first‐line therapy for patients with breast cancer (<scp>CBCRT</scp>01)
|International Journal of Cancer|2017|30
STK3 Suppresses Ovarian Cancer Progression by Activating NF‐ <i>κ</i> B Signaling to Recruit CD8 <sup>+</sup> T‐Cells
|Journal of Immunology Research|2020|14
Exosomal miR-543 Inhibits the Proliferation of Ovarian Cancer by Targeting IGF2
|Journal of Immunology Research|2022|12